LENZ

LENZ Therapeutics
LENZ

Overview Fund Activity

94 hedge funds and large institutions have $573M invested in LENZ Therapeutics in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 8 closing their positions.

Holders
94
Holders Change
+16
Holders Change %
+20.51%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
33
Reduced
20
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PBA
1
Paradigm Biocapital Advisors
New York
$22.2M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$23.8M
3
BlackRock
3
BlackRock
New York
$33.4M
4
State Street
4
State Street
Massachusetts
$14.3M
5
UBS Group
5
UBS Group
Switzerland
$2.48M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
SB
2
Samsara BioCapital
California
$28.5M
3
PHP
3
Parkman Healthcare Partners
Connecticut
$0
4
SSA
4
Schonfeld Strategic Advisors
New York
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$22.6M
Name Market Value Shares Shares
Change 		Shares
Change %
PS
101
Planned Solutions
California
– – -217 Closed
AAP
102
Arax Advisory Partners
Colorado
– – -12 Closed
CPA
103
Capital Performance Advisors
California
– – -6 Closed
CFGS
104
Concourse Financial Group Securities
Alabama
– – – –
1 2 3 4
5